{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:30:20Z","timestamp":1792791020022,"version":"4.5.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The research project of Health Commission of Hubei Province","award":["WJ2025Q020"],"award-info":[{"award-number":["WJ2025Q020"]}],"id":[{"id":"https:\/\/ror.org\/02g4yc525","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"crossref","award":["No.2025AFB803"],"award-info":[{"award-number":["No.2025AFB803"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-24433-6","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T14:34:36Z","timestamp":1763476476000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Silibinin mitigates AKI-to-CKD transition via MAPK and PI3K\/AKT signaling pathways in Ischemia-Reperfusion injury"],"prefix":"10.1038","volume":"15","author":[{"given":"Sijin","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Jian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingsong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianxue","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"24433_CR1","doi-asserted-by":"publisher","first-page":"166532","DOI":"10.1016\/j.bbadis.2022.166532","volume":"1868","author":"A Kale","year":"2022","unstructured":"Kale, A., Shelke, V., Sankrityayan, H., Dagar, N. & Gaikwad, A. B. Klotho restoration via ACE2 activation: A potential therapeutic strategy against acute kidney injury-diabetes comorbidity. Biochim. Biophys. Acta Mol. Basis Dis. 1868, 166532. https:\/\/doi.org\/10.1016\/j.bbadis.2022.166532 (2022).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"24433_CR2","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.kint.2018.08.036","volume":"95","author":"EJ See","year":"2019","unstructured":"See, E. J. et al. Long-term risk of adverse outcomes after acute kidney injury: A systematic review and meta-analysis of cohort studies using consensus definitions of exposure. Kidney Int. 95, 160\u2013172. https:\/\/doi.org\/10.1016\/j.kint.2018.08.036 (2019).","journal-title":"Kidney Int."},{"key":"24433_CR3","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.kint.2022.02.033","volume":"101","author":"S Sawhney","year":"2022","unstructured":"Sawhney, S. et al. Harmonization of epidemiology of acute kidney injury and acute kidney disease produces comparable findings across four geographic populations. Kidney Int. 101, 1271\u20131281. https:\/\/doi.org\/10.1016\/j.kint.2022.02.033 (2022).","journal-title":"Kidney Int."},{"key":"24433_CR4","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s00134-015-3934-7","volume":"41","author":"EAJ Hoste","year":"2015","unstructured":"Hoste, E. A. J. et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 41, 1411\u20131423. https:\/\/doi.org\/10.1007\/s00134-015-3934-7 (2015).","journal-title":"Intensive Care Med."},{"key":"24433_CR5","doi-asserted-by":"publisher","first-page":"e6497","DOI":"10.1136\/bmjopen-2014-006497","volume":"5","author":"S Sawhney","year":"2015","unstructured":"Sawhney, S., Mitchell, M., Marks, A., Fluck, N. & Black, C. Long-term prognosis after acute kidney injury (AKI): what is the role of baseline kidney function and recovery? A systematic review. BMJ Open. 5, e6497. https:\/\/doi.org\/10.1136\/bmjopen-2014-006497 (2015).","journal-title":"BMJ Open."},{"key":"24433_CR6","doi-asserted-by":"publisher","first-page":"101760","DOI":"10.1016\/j.eclinm.2022.101760","volume":"55","author":"C Su","year":"2023","unstructured":"Su, C. et al. Outcomes associated with acute kidney disease: A systematic review and meta-analysis. EClinicalMedicine 55, 101760. https:\/\/doi.org\/10.1016\/j.eclinm.2022.101760 (2023).","journal-title":"EClinicalMedicine"},{"key":"24433_CR7","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/ki.2012.208","volume":"82","author":"LS Chawla","year":"2012","unstructured":"Chawla, L. S. & Kimmel, P. L. Acute kidney injury and chronic kidney disease: an integrated clinical syndrome. Kidney Int. 82, 516\u2013524. https:\/\/doi.org\/10.1038\/ki.2012.208 (2012).","journal-title":"Kidney Int."},{"key":"24433_CR8","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/nrneph.2015.3","volume":"11","author":"DA Ferenbach","year":"2015","unstructured":"Ferenbach, D. A. & Bonventre, J. V. Mechanisms of maladaptive repair after AKI leading to accelerated kidney ageing and CKD. Nat. Rev. Nephrol. 11, 264\u2013276. https:\/\/doi.org\/10.1038\/nrneph.2015.3 (2015).","journal-title":"Nat. Rev. Nephrol."},{"key":"24433_CR9","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/MNH.0000000000000605","volume":"29","author":"SM Yu","year":"2020","unstructured":"Yu, S. M. & Bonventre, J. V. Acute kidney injury and maladaptive tubular repair leading to renal fibrosis. Curr. Opin. Nephrol. Hypertens. 29, 310\u2013318. https:\/\/doi.org\/10.1097\/MNH.0000000000000605 (2020).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"24433_CR10","doi-asserted-by":"publisher","unstructured":"Zhang, X., Agborbesong, E. & Li, X. The role of mitochondria in acute kidney injury and chronic kidney disease and its therapeutic potential. Int. J. Mol. Sci. 22, https:\/\/doi.org\/10.3390\/ijms222011253 (2021).","DOI":"10.3390\/ijms222011253"},{"key":"24433_CR11","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1681\/ASN.2015010006","volume":"26","author":"MA Venkatachalam","year":"2015","unstructured":"Venkatachalam, M. A., Weinberg, J. M., Kriz, W. & Bidani, A. K. Failed tubule recovery, AKI-CKD transition, and kidney disease progression. J. Am. Soc. Nephrol. 26, 1765\u20131776. https:\/\/doi.org\/10.1681\/ASN.2015010006 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"24433_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/s41581-023-00694-0","volume":"19","author":"AB Sanz","year":"2023","unstructured":"Sanz, A. B., Sanchez-Ni\u00f1o, M. D., Ramos, A. M. & Ortiz, A. Regulated cell death pathways in kidney disease. Nat. Rev. Nephrol. 19, 281\u2013299. https:\/\/doi.org\/10.1038\/s41581-023-00694-0 (2023).","journal-title":"Nat. Rev. Nephrol."},{"key":"24433_CR13","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrneph.2017.107","volume":"13","author":"P Bhargava","year":"2017","unstructured":"Bhargava, P. & Schnellmann, R. G. Mitochondrial energetics in the kidney. Nat. Rev. Nephrol. 13, 629\u2013646. https:\/\/doi.org\/10.1038\/nrneph.2017.107 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"24433_CR14","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12986-015-0044-z","volume":"12","author":"S Granata","year":"2015","unstructured":"Granata, S. et al. A new therapeutic target in chronic kidney disease. Nutr. Metab. (Lond). 12, 49. https:\/\/doi.org\/10.1186\/s12986-015-0044-z (2015).","journal-title":"Nutr. Metab. (Lond)"},{"key":"24433_CR15","doi-asserted-by":"publisher","first-page":"3356","DOI":"10.1681\/ASN.2015020177","volume":"27","author":"R Lan","year":"2016","unstructured":"Lan, R. et al. Mitochondrial pathology and glycolytic shift during proximal tubule atrophy after ischemic AKI. J. Am. Soc. Nephrol. 27, 3356\u20133367. https:\/\/doi.org\/10.1681\/ASN.2015020177 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"24433_CR16","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.4110\/in.2018.18.e27","volume":"18","author":"JS Roh","year":"2018","unstructured":"Roh, J. S. & Sohn, D. H. Damage-Associated molecular patterns in inflammatory diseases. Immune Netw. 18, e27. https:\/\/doi.org\/10.4110\/in.2018.18.e27 (2018).","journal-title":"Immune Netw."},{"key":"24433_CR17","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.7150\/thno.50905","volume":"11","author":"M Zhao","year":"2021","unstructured":"Zhao, M. et al. Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic acute kidney injury by disrupting TFAM-mediated MtDNA maintenance. Theranostics 11, 1845\u20131863. https:\/\/doi.org\/10.7150\/thno.50905 (2021).","journal-title":"Theranostics"},{"key":"24433_CR18","doi-asserted-by":"publisher","first-page":"F1501","DOI":"10.1152\/ajprenal.00195.2018","volume":"315","author":"Y Sato","year":"2018","unstructured":"Sato, Y. & Yanagita, M. Immune cells and inflammation in AKI to CKD progression. Am. J. Physiol. Ren. Physiol. 315, F1501\u2013F1512. https:\/\/doi.org\/10.1152\/ajprenal.00195.2018 (2018).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"24433_CR19","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1007\/s00467-020-04866-z","volume":"36","author":"K Peasley","year":"2021","unstructured":"Peasley, K., Chiba, T., Goetzman, E. & Sims-Lucas, S. Sirtuins play critical and diverse roles in acute kidney injury. Pediatr. Nephrol. 36, 3539\u20133546. https:\/\/doi.org\/10.1007\/s00467-020-04866-z (2021).","journal-title":"Pediatr. Nephrol."},{"key":"24433_CR20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12906-023-04330-z","volume":"24","author":"W Zhao","year":"2024","unstructured":"Zhao, W. et al. Diosmin ameliorates renal fibrosis through Inhibition of inflammation by regulating SIRT3-mediated NF-\u03baB p65 nuclear translocation. BMC Complement. Med. Ther. 24, 29. https:\/\/doi.org\/10.1186\/s12906-023-04330-z (2024).","journal-title":"BMC Complement. Med. Ther."},{"key":"24433_CR21","doi-asserted-by":"publisher","unstructured":"Song, N., Thaiss, F. & Guo, L. NF\u03baB and kidney injury. Front. Immunol. 10, https:\/\/doi.org\/10.3389\/fimmu.2019.00815 (2019).","DOI":"10.3389\/fimmu.2019.00815"},{"key":"24433_CR22","doi-asserted-by":"publisher","unstructured":"Nishida, K. et al. Recombinant Long-Acting thioredoxin ameliorates AKI to CKD transition via modulating renal oxidative stress and inflammation. Int. J. Mol. Sci. 22, https:\/\/doi.org\/10.3390\/ijms22115600 (2021).","DOI":"10.3390\/ijms22115600"},{"key":"24433_CR23","doi-asserted-by":"publisher","first-page":"7531","DOI":"10.1007\/s00210-024-03172-x","volume":"397","author":"P Zare Mehrjerdi","year":"2024","unstructured":"Zare Mehrjerdi, P., Asadi, S., Ehsani, E., Askari, V. R. & Baradaran Rahimi, V. Silibinin as a major component of milk Thistle seed provides promising influences against diabetes and its complications: A systematic review. Naunyn Schmiedebergs Arch. Pharmacol. 397, 7531\u20137549. https:\/\/doi.org\/10.1007\/s00210-024-03172-x (2024).","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"24433_CR24","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1002\/ptr.6171","volume":"32","author":"L Abenavoli","year":"2018","unstructured":"Abenavoli, L. et al. Milk Thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases. Phytother Res. 32, 2202\u20132213. https:\/\/doi.org\/10.1002\/ptr.6171 (2018).","journal-title":"Phytother Res."},{"key":"24433_CR25","doi-asserted-by":"publisher","first-page":"176906","DOI":"10.1016\/j.ejphar.2024.176906","volume":"981","author":"S Ashique","year":"2024","unstructured":"Ashique, S. et al. Unlocking the possibilities of therapeutic potential of Silymarin and Silibinin against neurodegenerative Diseases-A mechanistic overview. Eur. J. Pharmacol. 981, 176906. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176906 (2024).","journal-title":"Eur. J. Pharmacol."},{"key":"24433_CR26","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.ejmech.2016.07.070","volume":"123","author":"N Polachi","year":"2016","unstructured":"Polachi, N. et al. Modulatory effects of Silibinin in various cell signaling pathways against liver disorders and cancer - a comprehensive review. Eur. J. Med. Chem. 123, 577\u2013595. https:\/\/doi.org\/10.1016\/j.ejmech.2016.07.070 (2016).","journal-title":"Eur. J. Med. Chem."},{"key":"24433_CR27","doi-asserted-by":"publisher","unstructured":"Yang, L. et al. Silibinin improves nonalcoholic fatty liver by regulating the expression of miR\u2013122: An in vitro and in vivo study. Mol. Med. Rep. 23, https:\/\/doi.org\/10.3892\/mmr.2021.11974 (2021).","DOI":"10.3892\/mmr.2021.11974"},{"key":"24433_CR28","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s12272-018-1047-x","volume":"41","author":"C Chu","year":"2018","unstructured":"Chu, C. et al. Role of Silibinin in the management of diabetes mellitus and its complications. Arch. Pharm. Res. 41, 785\u2013796. https:\/\/doi.org\/10.1007\/s12272-018-1047-x (2018).","journal-title":"Arch. Pharm. Res."},{"key":"24433_CR29","doi-asserted-by":"publisher","first-page":"4629","DOI":"10.2147\/DDDT.S483140","volume":"18","author":"M Selc","year":"2024","unstructured":"Selc, M., Macova, R. & Babelova, A. Novel strategies enhancing bioavailability and therapeutical potential of Silibinin for treatment of liver disorders. Drug Des. Devel Ther. 18, 4629\u20134659. https:\/\/doi.org\/10.2147\/DDDT.S483140 (2024).","journal-title":"Drug Des. Devel Ther."},{"key":"24433_CR30","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.2174\/1871520620666191220142741","volume":"20","author":"A Binienda","year":"2020","unstructured":"Binienda, A., Ziolkowska, S. & Pluciennik, E. The anticancer properties of silibinin: its molecular mechanism and therapeutic effect in breast cancer. Anticancer Agents Med. Chem. 20, 1787\u20131796. https:\/\/doi.org\/10.2174\/1871520620666191220142741 (2020).","journal-title":"Anticancer Agents Med. Chem."},{"key":"24433_CR31","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.3892\/ijmm.2020.4521","volume":"45","author":"Y Fan","year":"2020","unstructured":"Fan, Y. et al. Silibinin inhibits epithelial\u2013mesenchymal transition of renal cell carcinoma through autophagy\u2013dependent Wnt\/\u03b2\u2013catenin signaling. Int. J. Mol. Med. 45, 1341\u20131350. https:\/\/doi.org\/10.3892\/ijmm.2020.4521 (2020).","journal-title":"Int. J. Mol. Med."},{"key":"24433_CR32","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.2147\/DDDT.S209981","volume":"13","author":"K Liu","year":"2019","unstructured":"Liu, K. et al. Silibinin attenuates high-fat diet-induced renal fibrosis of diabetic nephropathy. Drug Des. Devel Ther. 13, 3117\u20133126. https:\/\/doi.org\/10.2147\/DDDT.S209981 (2019).","journal-title":"Drug Des. Devel Ther."},{"key":"24433_CR33","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2147\/DDDT.S224308","volume":"14","author":"R Liu","year":"2020","unstructured":"Liu, R. et al. Silibinin augments the antifibrotic effect of Valsartan through inactivation of TGF-\u03b21 signaling in kidney. Drug Des. Devel Ther. 14, 603\u2013611. https:\/\/doi.org\/10.2147\/DDDT.S224308 (2020).","journal-title":"Drug Des. Devel Ther."},{"key":"24433_CR34","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1007\/s13577-019-00314-9","volume":"33","author":"Z Ma","year":"2020","unstructured":"Ma, Z., Zang, W., Wang, H. & Wei, X. Silibinin enhances anti-renal fibrosis effect of MK-521 via downregulation of TGF-\u03b2 signaling pathway. Hum. Cell. 33, 330\u2013336. https:\/\/doi.org\/10.1007\/s13577-019-00314-9 (2020).","journal-title":"Hum. Cell"},{"key":"24433_CR35","doi-asserted-by":"publisher","unstructured":"Lim, J. O. et al. Silibinin attenuates silica dioxide Nanoparticles-Induced inflammation by suppressing TXNIP\/MAPKs\/AP-1 signaling. Cells 9, https:\/\/doi.org\/10.3390\/cells9030678 (2020).","DOI":"10.3390\/cells9030678"},{"key":"24433_CR36","doi-asserted-by":"publisher","first-page":"F1105","DOI":"10.1152\/ajprenal.00285.2020","volume":"319","author":"M Jiang","year":"2020","unstructured":"Jiang, M. et al. Mitochondrial dysfunction and the AKI-to-CKD transition. Am. J. Physiol. Ren. Physiol. 319, F1105\u2013F1116. https:\/\/doi.org\/10.1152\/ajprenal.00285.2020 (2020).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"24433_CR37","doi-asserted-by":"publisher","unstructured":"Chang, L., Chao, Y., Chiu, C., Chen, P. & Lin, H. Y. Mitochondrial signaling, the mechanisms of AKI-to-CKD transition and potential treatment targets. Int. J. Mol. Sci. 25, https:\/\/doi.org\/10.3390\/ijms25031518 (2024).","DOI":"10.3390\/ijms25031518"},{"key":"24433_CR38","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.semnephrol.2020.01.008","volume":"40","author":"DR Mcilroy","year":"2020","unstructured":"Mcilroy, D. R., Lopez, M. G. & Billings, F. T. T. Perioperative clinical trials in AKI. Semin Nephrol. 40, 173\u2013187. https:\/\/doi.org\/10.1016\/j.semnephrol.2020.01.008 (2020).","journal-title":"Semin Nephrol."},{"key":"24433_CR39","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1097\/MCC.0000000000000881","volume":"27","author":"K Saadat-Gilani","year":"2021","unstructured":"Saadat-Gilani, K. & Zarbock, A. Perioperative renal protection. Curr. Opin. Crit. Care. 27, 676\u2013685. https:\/\/doi.org\/10.1097\/MCC.0000000000000881 (2021).","journal-title":"Curr. Opin. Crit. Care"},{"key":"24433_CR40","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3109\/13880209.2014.942787","volume":"53","author":"M Khoshnoodi","year":"2015","unstructured":"Khoshnoodi, M., Fakhraei, N. & Dehpour, A. R. Possible involvement of nitric oxide in antidepressant-like effect of Silymarin in male mice. Pharm. Biol. 53, 739\u2013745. https:\/\/doi.org\/10.3109\/13880209.2014.942787 (2015).","journal-title":"Pharm. Biol."},{"key":"24433_CR41","doi-asserted-by":"publisher","first-page":"103360","DOI":"10.1016\/j.redox.2024.103360","volume":"77","author":"Y Deng","year":"2024","unstructured":"Deng, Y. et al. Silibinin attenuates ferroptosis in acute kidney injury by targeting FTH1. Redox Biol. 77, 103360. https:\/\/doi.org\/10.1016\/j.redox.2024.103360 (2024).","journal-title":"Redox Biol."},{"key":"24433_CR42","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s10735-022-10089-3","volume":"53","author":"F Yang","year":"2022","unstructured":"Yang, F. et al. Silibinin ameliorates cisplatin-induced acute kidney injury via activating Nfe2l1-mediated antioxidative response to suppress the ROS\/MAPK signaling pathway. J. Mol. Histol. 53, 729\u2013740. https:\/\/doi.org\/10.1007\/s10735-022-10089-3 (2022).","journal-title":"J. Mol. Histol."},{"key":"24433_CR43","doi-asserted-by":"publisher","first-page":"13284","DOI":"10.1021\/acs.jafc.3c01880","volume":"71","author":"B Zhang","year":"2023","unstructured":"Zhang, B. et al. Nephroprotective effects of Cardamonin on renal ischemia reperfusion Injury\/UUO-Induced renal fibrosis. J. Agric. Food Chem. 71, 13284\u201313303. https:\/\/doi.org\/10.1021\/acs.jafc.3c01880 (2023).","journal-title":"J. Agric. Food Chem."},{"key":"24433_CR44","doi-asserted-by":"publisher","first-page":"696542","DOI":"10.3389\/fcell.2021.696542","volume":"9","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y. et al. Signaling pathways involved in diabetic renal fibrosis. Front. Cell. Dev. Biol. 9, 696542. https:\/\/doi.org\/10.3389\/fcell.2021.696542 (2021).","journal-title":"Front. Cell. Dev. Biol."},{"key":"24433_CR45","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1017\/S1462399411002109","volume":"14","author":"SM Schultze","year":"2012","unstructured":"Schultze, S. M., Hemmings, B. A., Niessen, M. & Tschopp, O. PI3K\/AKT, MAPK and AMPK signalling: protein kinases in glucose homeostasis. Expert Rev. Mol. Med. 14, e1. https:\/\/doi.org\/10.1017\/S1462399411002109 (2012).","journal-title":"Expert Rev. Mol. Med."},{"key":"24433_CR46","doi-asserted-by":"publisher","unstructured":"Cui, X. et al. Scutellariae radix and coptidis rhizoma improve glucose and lipid metabolism in T2DM rats via regulation of the metabolic profiling and MAPK\/PI3K\/Akt signaling pathway. Int. J. Mol. Sci. 19, https:\/\/doi.org\/10.3390\/ijms19113634 (2018).","DOI":"10.3390\/ijms19113634"},{"key":"24433_CR47","doi-asserted-by":"publisher","unstructured":"Shorning, B. Y., Dass, M. S., Smalley, M. J. & Pearson, H. B. The PI3K-AKT-mTOR pathway and prostate cancer: At the crossroads of AR, MAPK, and WNT signaling. Int. J. Mol. Sci. 21, https:\/\/doi.org\/10.3390\/ijms21124507 (2020).","DOI":"10.3390\/ijms21124507"},{"key":"24433_CR48","doi-asserted-by":"publisher","first-page":"F1098","DOI":"10.1152\/ajprenal.00199.2018","volume":"315","author":"Y Fu","year":"2018","unstructured":"Fu, Y. et al. Rodent models of AKI-CKD transition. Am. J. Physiol. Ren. Physiol. 315, F1098\u2013F1106. https:\/\/doi.org\/10.1152\/ajprenal.00199.2018 (2018).","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"24433_CR49","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nm.2144","volume":"16","author":"L Yang","year":"2010","unstructured":"Yang, L., Besschetnova, T. Y., Brooks, C. R., Shah, J. V. & Bonventre, J. V. Epithelial cell cycle arrest in G2\/M mediates kidney fibrosis after injury. Nat. Med. 16, 535\u2013543. https:\/\/doi.org\/10.1038\/nm.2144 (2010) (1p-143p).","journal-title":"Nat. Med."},{"key":"24433_CR50","doi-asserted-by":"publisher","unstructured":"Aranda-Rivera, A. K., Cruz-Gregorio, A., Aparicio-Trejo, O. E. & Pedraza-Chaverri, J. Mitochondrial redox signaling and oxidative stress in kidney diseases. Biomolecules 11, https:\/\/doi.org\/10.3390\/biom11081144 (2021).","DOI":"10.3390\/biom11081144"},{"key":"24433_CR51","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nrneph.2017.126","volume":"13","author":"X Yang","year":"2017","unstructured":"Yang, X. et al. CD36 in chronic kidney disease: novel insights and therapeutic opportunities. Nat. Rev. Nephrol. 13, 769\u2013781. https:\/\/doi.org\/10.1038\/nrneph.2017.126 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"24433_CR52","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s10020-024-00994-6","volume":"30","author":"Y Shang","year":"2024","unstructured":"Shang, Y. et al. FUT8 upregulates CD36 and its core fucosylation to accelerate pericyte-myofibroblast transition through the mitochondrial-dependent apoptosis pathway during AKI-CKD. Mol. Med. 30, 222. https:\/\/doi.org\/10.1186\/s10020-024-00994-6 (2024).","journal-title":"Mol. Med."},{"key":"24433_CR53","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.semcancer.2020.09.014","volume":"73","author":"HS Tuli","year":"2021","unstructured":"Tuli, H. S. et al. Path of Silibinin from diet to medicine: A dietary polyphenolic flavonoid having potential anti-cancer therapeutic significance. Semin Cancer Biol. 73, 196\u2013218. https:\/\/doi.org\/10.1016\/j.semcancer.2020.09.014 (2021).","journal-title":"Semin Cancer Biol."},{"key":"24433_CR54","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.1111\/bph.16431","volume":"181","author":"Y Bai","year":"2024","unstructured":"Bai, Y. et al. Silibinin, a commonly used therapeutic agent for non-alcohol fatty liver disease, functions through upregulating intestinal expression of fibroblast growth factor 15\/19. Br. J. Pharmacol. 181, 3663\u20133684. https:\/\/doi.org\/10.1111\/bph.16431 (2024).","journal-title":"Br. J. Pharmacol."},{"key":"24433_CR55","doi-asserted-by":"publisher","unstructured":"Li, P. et al. Anti-Tumor activity and mechanism of silibinin based on network pharmacology and experimental verification. Molecules 29, https:\/\/doi.org\/10.3390\/molecules29081901 (2024).","DOI":"10.3390\/molecules29081901"},{"key":"24433_CR56","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1159\/000529710","volume":"113","author":"F Pecori Giraldi","year":"2023","unstructured":"Pecori Giraldi, F., Cassarino, M. F., Sesta, A., Lasio, G. & Losa, M. Silibinin, an HSP90 Inhibitor, on human ACTH-Secreting adenomas. Neuroendocrinology 113, 606\u2013614. https:\/\/doi.org\/10.1159\/000529710 (2023).","journal-title":"Neuroendocrinology"},{"key":"24433_CR57","doi-asserted-by":"publisher","first-page":"64","DOI":"10.31083\/j.fbl2804064","volume":"28","author":"AI Jo","year":"2023","unstructured":"Jo, A. I. & Kim, M. Silibinin inhibits cell invasion through the Inhibition of MMPs, p-p38, and IL-1\u03b2 in human fibrosarcoma cells. Front. Biosci. (Landmark Ed). 28, 64. https:\/\/doi.org\/10.31083\/j.fbl2804064 (2023).","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"24433_CR58","doi-asserted-by":"publisher","first-page":"109691","DOI":"10.1016\/j.abb.2023.109691","volume":"744","author":"P Liu","year":"2023","unstructured":"Liu, P. et al. Silibinin ameliorates STING-mediated neuroinflammation via downregulation of ferroptotic damage in a sporadic alzheimer\u2019s disease model. Arch. Biochem. Biophys. 744, 109691. https:\/\/doi.org\/10.1016\/j.abb.2023.109691 (2023).","journal-title":"Arch. Biochem. Biophys."},{"key":"24433_CR59","doi-asserted-by":"publisher","first-page":"153598","DOI":"10.1016\/j.tox.2023.153598","volume":"495","author":"W Li","year":"2023","unstructured":"Li, W. et al. Silibinin exerts neuroprotective effects against cerebral hypoxia\/reoxygenation injury by activating the GAS6\/Axl pathway. Toxicology 495, 153598. https:\/\/doi.org\/10.1016\/j.tox.2023.153598 (2023).","journal-title":"Toxicology"},{"key":"24433_CR60","doi-asserted-by":"publisher","unstructured":"Choi, S. et al. Silibinin downregulates types i and III collagen expression via suppression of the mTOR signaling pathway. Int. J. Mol. Sci. 24, https:\/\/doi.org\/10.3390\/ijms241814386 (2023).","DOI":"10.3390\/ijms241814386"},{"key":"24433_CR61","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.21873\/invivo.13681","volume":"38","author":"H Im","year":"2024","unstructured":"Im, H. et al. Silibinin mitigates vanadium-induced lung injury via the TLR4\/MAPK\/NF-\u03baB pathway in mice. Vivo 38, 2179\u20132189. https:\/\/doi.org\/10.21873\/invivo.13681 (2024).","journal-title":"Vivo"},{"key":"24433_CR62","doi-asserted-by":"publisher","first-page":"109939","DOI":"10.1016\/j.exer.2024.109939","volume":"244","author":"X Wu","year":"2024","unstructured":"Wu, X. et al. Silibinin attenuates TGF-\u03b22-induced fibrogenic changes in human trabecular meshwork cells by targeting JAK2\/STAT3 and PI3K\/AKT signaling pathways. Exp. Eye Res. 244, 109939. https:\/\/doi.org\/10.1016\/j.exer.2024.109939 (2024).","journal-title":"Exp. Eye Res."},{"key":"24433_CR63","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1681\/ASN.2018111126","volume":"30","author":"J Sun","year":"2019","unstructured":"Sun, J. et al. Mitochondria in Sepsis-Induced AKI. J. Am. Soc. Nephrol. 30, 1151\u20131161. https:\/\/doi.org\/10.1681\/ASN.2018111126 (2019).","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24433-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24433-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24433-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T03:03:37Z","timestamp":1763521417000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-24433-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24433"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-24433-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"10 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40609"}}